A homologous form of human interleukin 16 is implicated in microglia recruitment following nervous system injury in leech Hirudo medicinalis

GLIA

Volumn 58, Issue 14, 2010, Pages 1649-1662

  Croq, Françoise ^a   Vizioli, Jacopo ^a   Tuzova, Marina ^b   Tahtouh, Muriel ^a   Sautiere, Pierre Eric ^a   Van Camp, Christelle ^a   Salzet, Michel ^a   Cruikshank, William W ^b   Pestel, Joel ^a   Lefebvre, Christophe ^a  

^a UNIV LILLE   (France)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chemotaxis; Invertebrate cytokine; Microglial cells; Nerve cord repair

Indexed keywords

INTERLEUKIN 16;

ARTICLE; CD4+ T LYMPHOCYTE; CELL DAMAGE; CELL MIGRATION; CELL REGENERATION; CELL STRUCTURE; CHEMOTAXIS; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; LEECH; LYMPHOCYTE; MICROGLIA; MOLECULAR INTERACTION; NERVOUS SYSTEM INJURY; NONHUMAN; PRIORITY JOURNAL; PROTEIN TRANSPORT; SCANNING TRANSMISSION ELECTRON MICROSCOPY; TRANSMISSION ELECTRON MICROSCOPY; WESTERN BLOTTING;

EID: 77957872102     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.21036     Document Type: Article

References (57)

1. Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ. 1997. Gapped BLAST and PSI-BLAST: A new generation of protein database search programs. Nucleic Acids Res 25: 3389-3402.
2. Bannert N, Adler HS, Werner A, Baier M, Kurth R. 1998. Molecular cloning and sequence analysis of interleukin 16 from nonhuman primates and from the mouse. Immunogenetics 47: 390-397.
3. Bellini A, Yoshimura H, Vittori E, Marini M, Mattoli S. 1993. Bronchial epithelial cells of patients with asthma release chemoattractant factors for T lymphocytes. J Allergy Clin Immunol 92: 412-424.
4. Blackshaw SE, Babington EJ, Emes RD, Malek J, Wang WZ. 2004. Identifying genes for neuron survival and axon outgrowth in Hirudo medicinalis. J Anat 204: 13-24.
5. Bray DF, Bagu J, Koegler P. 1993. Comparison of hexamethyldisilazane (HMDS), Peldri II, critical-point drying methods for scanning electron microscopy of biological specimens. Microsc Res Tech 26: 489-495.
6. Center DM, Cruikshank W. 1982. Modulation of lymphocyte migration by human lymphokines. I. Identification and characterization of chemoattractant activity for lymphocytes from mitogen-stimulated mononuclear cells. J Immunol 128: 2563-2568.
7. Center DM, Kornfeld H, Cruikshank WW. 1996. Interleukin 16 and its function as a CD4 ligand. Immunol Today 17: 476-481.
8. Center DM, Kornfeld H, Ryan TC, Cruikshank WW. 2000. Interleukin 16: Implications for CD4 functions and HIV-1 progression. Immunol Today 21: 273-280.
9. Chen A, Kumar SM, Sahley CL, Muller KJ. 2000. Nitric oxide influences injury-induced microglial migration and accumulation in the leech CNS. J Neurosci 20: 1036-1043.
10. Chupp GL, Wright EA, Wu D, Vallen-Mashikian M, Cruikshank WW, Center DM, Kornfeld H, Berman JS. 1998. Tissue and T cell distribution of precursor and mature IL-16. J Immunol 161: 3114-3119.
11. Corpet F. 1988. Multiple sequence alignment with hierarchical clustering. Nucleic Acids Res 16: 10881-10890.
12. Cruikshank W, Center DM. 1982. Modulation of lymphocyte migration by human lymphokines. II. Purification of a lymphotactic factor (LCF). J Immunol 128: 2569-2574.
13. del Rio-Hortega P. 1932. Cytology and cellular pathology of the nervous system. In: Penfield W, editor. Microglia. New York: P B Hoebaer. pp 483-534.
14. Duan Y, Panoff J, Burrell BD, Sahley CL, Muller KJ. 2005. Repair and regeneration of functional synaptic connections: Cellular and molecular interactions in the leech. Cell Mol Neurobiol 25: 441-450.
15. Elliott EJ, Muller KJ. 1981. Long-term survival of glial segments during nerve regeneration in the leech. Brain Res 218: 99-113.
16. Glass WG, Sarisky RT, Vecchio AM. 2006. Not-so-sweet sixteen: The role of IL-16 in infectious and immune-mediated inflammatory diseases. J Interferon Cytokine Res 26: 511-520.
17. Guo LH, Mittelbronn M, Brabeck C, Mueller CA, Schluesener HJ. 2004. Expression of interleukin-16 by microglial cells in inflammatory, autoimmune, and degenerative lesions of the rat brain. J Neuroimmunol 146: 39-45.
18. Hanisch UK. 2002. Microglia as a source and target of cytokines. Glia 40: 140-155.
19. Hanisch UK, Kettenmann H. 2007. Microglia: Active sensor and versatile effector cells in the normal and pathologic brain. Nat Neurosci 10: 1387-1394.
20. Jelen F, Oleksy A, Smietana K, Otlewski J. 2003. PDZ domains-Common players in the cell signaling. Acta Biochim Polym 50: 985-1017.
21. Karlin S, Altschul SF. 1990. Methods for assessing the statistical significance of molecular sequence features by using general scoring schemes. Proc Natl Acad Sci USA 87: 2264-2268.
22. Keane J, Nicoll J, Kim S, Wu DM, Cruikshank WW, Brazer W, Natke B, Zhang Y, Center DM, Kornfeld H. 1998. Conservation of structure and function between human and murine IL-16. J Immunol 160: 5945-5954.
23. Köhidai L. 1995. Method for determination of chemoattraction in Tetrahymena pyriformis. Curr Microbiol 30: 251-253.
24. Kreutzberg GW. 1996. Microglia: A sensor for pathological events in the CNS. Trends Neurosci 19: 312-318.
25. Kumar SM, Porterfield DM, Muller KJ, Smith PJ, Sahley CL. 2001. Nerve injury induces a rapid efflux of nitric oxide (NO) detected with a novel NO microsensor. J Neurosci 21: 215-220.
26. Kurschner C, Yuzaki M. 1999. Neuronal interleukin-16 (NIL-16): A dual function PDZ domain protein. J Neurosci 19: 7770-7780.
27. Laberge S, Ernst P, Ghaffar O, Cruikshank WW, Kornfeld H, Center DM, Hamid Q. 1997. Increased expression of interleukin-16 in bronchial mucosa of subjects with atopic asthma. Am J Respir Cell Mol Biol 17: 193-202.
28. Liebrich M, Guo LH, Schluesener HJ, Schwab JM, Dietz K, Will BE, Meyermann R. 2007. Expression of interleukin-16 by tumor-associated macrophages/activated microglia in high-grade astrocytic brain tumors. Arch Immunol Ther Exp (Warsz) 55: 41-47.
29. Lim KG, Wan HC, Bozza PT, Resnick MB, Wong DT, Cruikshank WW, Kornfeld H, Center DM, Weller PF. 1996. Human eosinophils elaborate the lymphocyte chemoattractants. IL-16 (lymphocyte chemoattractant factor) and RANTES. J Immunol 156: 2566-2570.
30. Masuda-Nakagawa LM, Muller KJ, Nicholls JG. 1990. Accumulation of laminin and microglial cells at sites of injury and regeneration in the central nervous system of the leech. Proc Biol Sci 241: 201-206.
31. McGlade-McCulloh E, Morrissey AM, Norona F, Muller KJ. 1989. Individual microglia move rapidly and directly to nerve lesions in the leech central nervous system. Proc Natl Acad Sci USA 86: 1093-1097.
32. Mittelbronn M, Dietz K, Schluesener HJ, Meyermann R. 2001. Local distribution of microglia in the normal adult human central nervous system differs by up to one order of magnitude. Acta Neuropathol 101: 249-255.
33. Morgese VJ, Elliott EJ, Muller KJ. 1983. Microglial movement to sites of nerve lesion in the leech CNS. Brain Res 272: 166-170.
34. Mueller CA, Schluesener HJ, Conrad S, Pietsch T, Schwab JM. 2006. Spinal cord injury-induced expression of the immune-regulatory chemokine interleukin-16 caused by activated microglia/macrophages and CD8+ cells. J Neurosurg Spine 4: 233-240.
35. Muhlhahn P, Zweckstetter M, Georgescu J, Ciosto C, Renner C, Lanzendorfer M, Lang K, Ambrosius D, Baier M, Kurth R, et al. 1998. Structure of interleukin 16 resembles a PDZ domain with an occluded peptide binding site. Nat Struct Biol 5: 682-686.
36. Nardelli-Haefliger D, Shankland M. 1992. Lox2, a putative leech segment identity gene, is expressed in the same segmental domain in different stem cell lineages. Development 116: 697-710.
37. Ngu EM, Sahley CL, Muller KJ. 2007. Reduced axon sprouting after treatment that diminishes microglia accumulation at lesions in the leech CNS. J Comp Neurol 503: 101-109.
38. Nicoll J, Cruikshank WW, Brazer W, Liu Y, Center DM, Kornfeld H. 1999. Identification of domains in IL-16 critical for biological activity. J Immunol 163: 1827-1832.
39. Perry VH, Gordon S. 1988. Macrophages and microglia in the nervous system. Trends Neurosci 11: 273-277.
40. Rumsaeng V, Cruikshank WW, Foster B, Prussin C, Kirshenbaum AS, Davis TA, Kornfeld H, Center DM, Metcalfe DD. 1997. Human mast cells produce the CD4+ T lymphocyte chemoattractant factor, IL-16 J Immunol 159: 2904-2910.
41. Schluesener HJ, Seid K, Kretzschmar J, Meyermann R. 1996. Leukocyte chemotactic factor, a natural ligand to CD4, is expressed by lymphocytes and microglial cells of the MS plaque. J Neurosci Res 44: 606-611.
42. Schwab JM, Nguyen TD, Meyermann R, Schluesener HJ. 2001a. Human focal cerebral infarctions induce differential lesional interleukin-16 (IL-16) expression confined to infiltrating granulocytes, CD8+ T-lymphocytes and activated microglia/macrophages J Neuroimmunol 114: 232-241.
43. Schwab JM, Schluesener HJ, Seid K, Meyermann R. 2001b. IL-16 is differentially expressed in the developing human fetal brain by microglial cells in zones of neuropoesis. Int J Dev Neurosci 19: 93-100.
44. Sciaky D, Brazer W, Center DM, Cruikshank WW, Smith TJ. 2000. Cultured human fibroblasts express constitutive IL-16 mRNA: Cytokine induction of active IL-16 protein synthesis through a caspase-3-dependent mechanism. J Immunol 164: 3806-3814.
45. Sharma V, Sparks JL, Vail JD. 2000. Human B-cell lines constitutively express and secrete interleukin-16. Immunology 99: 266-271.
46. Skundric DS, Cai J, Cruikshank WW, Gveric D. 2006. Production of IL-16 correlates with CD4+ Th1 inflammation and phosphorylation of axonal cytoskeleton in multiple sclerosis lesions. J Neuroinflammation 3: 13.
47. Skundric DS, Dai R, Zakarian VL, Bessert D, Skoff RP, Cruikshank WW, Kurjakovic Z. 2005a. Anti-IL-16 therapy reduces CD4+ T-cell infiltration and improves paralysis and histopathology of relapsing EAE. J Neurosci Res 79: 680-693.
48. Skundric DS, Zhou W, Cruikshank WW, Dai R. 2005b. Increased levels of bioactive IL-16 correlate with disease activity during relapsing experimental autoimmune encephalomyelitis (EAE). J Autoimmun 25: 206-214.
49. Tastet C, Lescuyer P, Diemer H, Luche S, van Dorsselaer A, Rabilloud T. 2003. A versatile electrophoresis system for the analysis of high- and low-molecular-weight proteins. Electrophoresis 24: 1787-1794.
50. von Bernhardi R, Muller KJ. 1995. Repair of the central nervous system: Lessons from lesions in leeches. J Neurobiol 27: 353-366.
51. Wang WZ, Emes RD, Christoffers K, Verrall J, Blackshaw SE. 2005. Hirudo medicinalis: A platform for investigating genes in neural repair. Cell Mol Neurobiol 25: 427-440.
52. Wen Y, Shao JZ, Xiang LX, Fang W. 2006. Cloning, characterization and expression analysis of two Tetraodon nigroviridis interleukin-16 isoform genes. Comp Biochem Physiol B Biochem Mol Biol 144: 159-166.
53. Xu Y, Bolton B, Zipser B, Jellies J, Johansen KM, Johansen J. 1999. Gliarin and macrolin, two novel intermediate filament proteins specifically expressed in sets and subsets of glial cells in leech central nervous system. J Neurobiol 40: 244-253.
54. Zhang Y, Center DM, Wu DM, Cruikshank WW, Yuan J, Andrews DW, Kornfeld H. 1998. Processing and activation of pro-interleukin-16 by caspase-3. J Biol Chem 273: 1144-1149.
55. Zhang Y, Kornfeld H, Cruikshank WW, Kim S, Reardon CC, Center DM. 2001. Nuclear translocation of the N-terminal prodomain of interleukin-16. J Biol Chem 276: 1299-1303.
56. Zhang ZY, Zhang Z, Fauser U, Schluesener HJ. 2009. Expression of Interleukin-16 in sciatic nerves, spinal roots and spinal cords of experimental autoimmune neuritis rats. Brain Pathol 19: 205-213.
57. Zhao ML, Si Q, Lee SC. 2004. IL-16 expression in lymphocytes and microglia in HIV-1 encephalitis. Neuropathol Appl Neurobiol 30: 233-242.